ADP-Ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity

mBio

Volumn 5, Issue 6, 2014, Pages

  Bose, Santanu ^a   Segovia, Jesus A ^b   Somarajan, Sudha R ^b   Chang, Te Hung ^b   Kannan, T R ^b   Baseman, Joel B ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CARDS TOXIN; COMMUNITY ACQUIRED RESPIRATORY DISTRESS SYNDROME TOXIN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG; ADENOSINE DIPHOSPHATE; BACTERIAL PROTEIN; CARDS TOXIN, MYCOPLASMA PNEUMONIAE; CARRIER PROTEIN; NLRP3 PROTEIN, HUMAN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; INTERNALIZATION; MACROPHAGE; MOUSE; MYCOPLASMA PNEUMONIAE; NONHUMAN; PROTEIN PROCESSING; REGULATORY MECHANISM; ANIMAL; CELL CULTURE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); MYCOPLASMA; MYCOPLASMA PNEUMONIAE;

ADENOSINE DIPHOSPHATE; ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CARRIER PROTEINS; CELLS, CULTURED; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMASOMES; MACROPHAGES; MICE; MYCOPLASMA PNEUMONIAE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84920997431     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02186-14     Document Type: Article

References (65)

1. Davis BK, Wen H, Ting JP. 2011. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29:707–735. http://dx.doi.org/10.1146/annurev-immunol-031210-101405.
2. Dowling JK, O’Neill LA. 2012. Biochemical regulation of the inflammasome. Crit. Rev. Biochem. Mol. Biol. 47:424–443. http://dx.doi.org/10.3109/10409238.2012.694844.
3. Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G. 2009. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 10:241–247. http://dx.doi.org/10.1038/ni.1703.
4. Jin C, Flavell RA. 2010. Molecular mechanism of NLRP3 inflammasome activation. J. Clin. Immunol. 30:628–631. http://dx.doi.org/10.1007/s10875-010-9440-3.
5. Kanneganti TD. 2010. Central roles of NLRs and inflammasomes in viral infection. Nat. Rev. Immunol. 10:688–698. http://dx.doi.org/10.1038/nri2851.
6. Koizumi Y, Toma C, Higa N, Nohara T, Nakasone N, Suzuki T. 2012. Inflammasome activation via intracellular NLRs triggered by bacterial infection. Cell. Microbiol. 14:149–154. http://dx.doi.org/10.1111/j.1462-5822.2011.01707.x.
7. Lamkanfi M, Dixit VM. 2009. The inflammasomes. PLoS Pathog. 5:e1000510. http://dx.doi.org/10.1371/journal.ppat.1000510.
8. Rathinam VA, Vanaja SK, Fitzgerald KA. 2012. Regulation of inflammasome signaling. Nat. Immunol. 13:333–342. http://dx.doi.org/10.1038/ni.2237.
9. Schroder K, Tschopp J. 2010. The inflammasomes. Cell 140:821–832. http://dx.doi.org/10.1016/j.cell.2010.01.040.
10. Birrell MA, Eltom S. 2011. The role of the NLRP3 inflammasome in the pathogenesis of airway disease. Pharmacol. Ther. 130:364–370. http://dx.doi.org/10.1016/j.pharmthera.2011.03.007.
11. dos Santos G, Kutuzov MA, Ridge KM. 2012. The inflammasome in lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 303:L627–L633. http://dx.doi.org/10.1152/ajplung.00225.2012.
12. Krause K, Metz M, Makris M, Zuberbier T, Maurer M. 2012. The role of interleukin-1 in allergy-related disorders. Curr. Opin. Allergy Clin. Immunol. 12:477–484. http://dx.doi.org/10.1097/ACI.0b013e3283574d0c.
13. Gordon SB, Read RC. 2002. Macrophage defences against respiratory tract infections. Br. Med. Bull. 61:45–61. http://dx.doi.org/10.1093/bmb/61.1.45.
14. Lamkanfi M, Dixit VM. 2011. Modulation of inflammasome pathways by bacterial and viral pathogens. J. Immunol. 187:597–602. http://dx.doi.org/10.4049/jimmunol.1100229.
15. Segovia J, Sabbah A, Mgbemena V, Tsai SY, Chang TH, Berton MT, Morris IR, Allen IC, Ting JP, Bose S. 2012. TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One 7:e29695. http://dx.doi.org/10.1371/journal.pone.0029695.
16. Kannan TR, Baseman JB. 2006. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc. Natl. Acad. Sci. U. S. A. 103: 6724–6729. http://dx.doi.org/10.1073/pnas.0510644103.
17. Hardy RD, Coalson JJ, Peters J, Chaparro A, Techasaensiri C, Cantwell AM, Kannan TR, Baseman JB, Dube PH. 2009. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PLoS One 4:e7562. http://dx.doi.org/10.1371/journal.pone.0007562.
18. Kannan TR, Krishnan M, Ramasamy K, Becker A, Pakhomova ON, Hart PJ, Baseman JB. 2014. Functional mapping of community-acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating and receptorbinding activities. Mol. Microbiol. 93:568–581. http://dx.doi.org/10.1111/mmi.12680.
19. Kannan TR, Provenzano D, Wright JR, Baseman JB. 2005. Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect. Immun. 73:2828–2834. http://dx.doi.org/10.1128/IAI.73.5.2828-2834.2005.
20. Krishnan M, Kannan TR, Baseman JB. 2013. Mycoplasma pneumoniae CARDS toxin is internalized via clathrin-mediated endocytosis. PLoS One 8:e62706. http://dx.doi.org/10.1371/journal.pone.0062706.
21. Somarajan SR, Al-Asadi F, Ramasamy K, Pandranki L, Baseman JB, Kannan TR. 2014. AnnexinA2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells. mBio 5(4):e014974-14. http://dx.doi.org/10.1128/ mBio.01497-14.
22. Lopez-Castejon G, Luheshi NM, Compan V, High S, Whitehead RC, Flitsch S, Kirov A, Prudovsky I, Swanton E, Brough D. 2013. Deubiquitinases regulate the activity of caspase-1 and interleukin-1beta secretion via assembly of the inflammasome. J. Biol. Chem. 288:2721–2733. http://dx.doi.org/10.1074/jbc.M112.422238.
23. Harder J, Franchi L, Muñoz-Planillo R, Park JH, Reimer T, Núñez G. 2009. Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor. J. Immunol. 183:5823–5829. http://dx.doi.org/10.4049/jimmunol.0900444.
24. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, Roose- Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228–232. http://dx.doi.org/10.1038/nature04515.
25. McNeela EA, Burke A, Neill DR, Baxter C, Fernandes VE, Ferreira D, Smeaton S, El-Rachkidy R, McLoughlin RM, Mori A, Moran B, Fitzgerald KA, Tschopp J, Pétrilli V, Andrew PW, Kadioglu A, Lavelle EC. 2010. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 6:e1001191. http://dx.doi.org/10.1371/journal.ppat.1001191.
26. McCoy AJ, Koizumi Y, Higa N, Suzuki T. 2010. Differential regulation of caspase-1 activation via NLRP3/NLRC4 inflammasomes mediated by aerolysin and type III secretion system during Aeromonas veronii infection. J. Immunol. 185:7077–7084. http://dx.doi.org/10.4049/jimmunol.1002165.
27. McCoy AJ, Koizumi Y, Toma C, Higa N, Dixit V, Taniguchi S, Tschopp J, Suzuki T. 2010. Cytotoxins of the human pathogen Aeromonas hydrophila trigger, via the NLRP3 inflammasome, caspase-1 activation in macrophages. Eur. J. Immunol. 40:2797–2803. http://dx.doi.org/10.1002/eji.201040490.
28. Toma C, Higa N, Koizumi Y, Nakasone N, Ogura Y, McCoy AJ, Franchi L, Uematsu S, Sagara J, Taniguchi S, Tsutsui H, Akira S, Tschopp J, Núñez G, Suzuki T. 2010. PathogenicVibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa B signaling. J. Immunol. 184:5287–5297. http://dx.doi.org/10.4049/jimmunol.0903536.
29. Carlsson F, Kim J, Dumitru C, Barck KH, Carano RA, Sun M, Diehl L, Brown EJ. 2010. Host-detrimental role of Esx-1-mediated inflammasome activation in mycobacterial infection. PLoS Pathog. 6:e1000895. http://dx.doi.org/10.1371/journal.ppat.1000895.
30. Mishra BB, Moura-Alves P, Sonawane A, Hacohen N, Griffiths G, Moita LF, Anes E. 2010. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell. Microbiol. 12: 1046–1063. http://dx.doi.org/10.1111/j.1462-5822.2010.01450.x.
31. Abdul-Sater AA, Saïd-Sadier N, Padilla EV, Ojcius DM. 2010. Chlamydial infection of monocytes stimulates IL-1beta secretion through activation of the NLRP3 inflammasome. Microbes Infect. 12:652–661. http://dx.doi.org/10.1016/j.micinf.2010.04.008.
32. Duncan JA, Gao X, Huang MT, O’Connor BP, Thomas CE, Willingham SB, Bergstralh DT, Jarvis GA, Sparling PF, Ting JP. 2009. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J. Immunol. 182:6460–6469. http://dx.doi.org/10.4049/jimmunol.0802696.
33. He X, Mekasha S, Mavrogiorgos N, Fitzgerald KA, Lien E, Ingalls RR. 2010. Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. J. Immunol. 184:5743–5754. http://dx.doi.org/10.4049/jimmunol.0903937.
34. Huang MT, Taxman DJ, Holley-Guthrie EA, Moore CB, Willingham SB, Madden V, Parsons RK, Featherstone GL, Arnold RR, O’Connor BP, Ting JP. 2009. Critical role of apoptotic speck protein containing a caspase recruitment domain (ASC) and NLRP3 in causing necrosis and ASC speck formation induced by Porphyromonas gingivalis in human cells. J. Immunol. 182:2395–2404. http://dx.doi.org/10.4049/jimmunol.0800909.
35. Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT, Taxman DJ, Duncan JA, Ting JP. 2009. NLRP3 (NALP3, cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J. Immunol. 183: 2008–2015. http://dx.doi.org/10.4049/jimmunol.0900138.
36. Brodsky IE, Palm NW, Sadanand S, Ryndak MB, Sutterwala FS, Flavell RA, Bliska JB, Medzhitov R. 2010. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 7:376–387. http://dx.doi.org/10.1016/j.chom.2010.04.009.
37. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozören N, Jagirdar R, Inohara N, Vandenabeele P, Bertin J, Coyle A, Grant EP, Núñez G. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat. Immunol. 7:576–582. http://dx.doi.org/10.1038/ni1346.
38. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S, Dixit VM. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213–218. http://dx.doi.org/10.1038/nature02664.
39. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI, Aderem A. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 7:569–575. http://dx.doi.org/10.1038/ni1344.
40. Molofsky AB, Byrne BG, Whitfield NN, Madigan CA, Fuse ET, Tateda K, Swanson MS. 2006. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J. Exp. Med. 203: 1093–1104. http://dx.doi.org/10.1084/jem.20051659.
41. Sutterwala FS, Mijares LA, Li L, Ogura Y, Kazmierczak BI, Flavell RA. 2007. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 204:3235–3245. http://dx.doi.org/10.1084/jem.20071239.
42. Suzuki T, Franchi L, Toma C, Ashida H, Ogawa M, Yoshikawa Y, Mimuro H, Inohara N, Sasakawa C, Nuñez G. 2007. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog. 3:e111. http://dx.doi.org/10.1371/journal.ppat.0030111.
43. Zamboni DS, Kobayashi KS, Kohlsdorf T, Ogura Y, Long EM, Vance RE, Kuida K, Mariathasan S, Dixit VM, Flavell RA, Dietrich WF, Roy CR. 2006. TheBirc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat. Immunol. 7:318–325. http://dx.doi.org/10.1038/ni1305.
44. Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, Wu J, Datta P, McCormick M, Huang L, McDermott E, Eisenlohr L, Landel CP, Alnemri ES. 2010. TheAIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11:385–393. http://dx.doi.org/10.1038/ni.1859.
45. Jones JW, Kayagaki N, Broz P, Henry T, Newton K, O’Rourke K, Chan S, Dong J, Qu Y, Roose-Girma M, Dixit VM, Monack DM. 2010. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc. Natl. Acad. Sci. U. S. A. 107:9771–9776. http://dx.doi.org/10.1073/pnas.1003738107.
46. Boyden ED, Dietrich WF. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38:240–244. http://dx.doi.org/10.1038/ng1724.
47. Hsu L C, Ali SR, McGillivray S, Tseng PH, Mariathasan S, Humke EW, Eckmann L, Powell JJ, Nizet V, Dixit VM, Karin M. 2008. A NOD2- NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl. Acad. Sci. U. S. A. 105:7803–7808. http://dx.doi.org/10.1073/pnas.0802726105.
48. Medina JL, Coalson JJ, Brooks EG, Winter VT, Chaparro A, Principe MF, Kannan TR, Baseman JB, Dube PH. 2012. Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation. Am. J. Respir. Cell Mol. Biol. 46:815–822. http://dx.doi.org/10.1165/rcmb.2011-0135OC.
49. Peters J, Singh H, Brooks EG, Diaz J, Kannan TR, Coalson JJ, Baseman JG, Cagle M, Baseman JB. 2011. Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma. Chest 140:401–407. http://dx.doi.org/10.1378/chest.11-0221.
50. Thomas SS, Chhabra SK. 2003. A study on the serum levels of interleukin-1beta in bronchial asthma. J. Indian Med. Assoc. 101:286.
51. Konno S, Gonokami Y, Kurokawa M, Kawazu K, Asano K, Okamoto K, Adachi M. 1996. Cytokine concentrations in sputum of asthmatic patients. Int. Arch. Allergy Immunol. 109:73–78. http://dx.doi.org/10.1159/000237234.
52. Underwood SL, Haddad E-B, Birrell MA, McCluskie K, Pecoraro M, Dabrowski D, Webber SE, Foster ML, Belvisi MG. 2002. Functional characterization and biomarker identification in the Brown Norway model of allergic airway inflammation. Br. J. Pharmacol. 137:263–275. http://dx.doi.org/10.1038/sj.bjp.0704865.
53. Broide DH, Campbell K, Gifford T, Sriramarao P. 2000. Inhibition of eosinophilic inflammation in allergen-challenged, IL-1 receptor type 1-deficient mice is associated with reduced eosinophil rolling and adhesion on vascular endothelium. Blood 95:263–269.
54. Schmitz N, Kurrer M, Kopf M. 2003. TheIL-1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur. J. Immunol. 33:991–1000. http://dx.doi.org/10.1002/eji.200323801.
55. Nakae S, Komiyama Y, Yokoyama H, Nambu A, Umeda M, Iwase M, Homma I, Sudo K, Horai R, Asano M, Iwakura Y. 2003. IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response. Int. Immunol. 15:483–490. http://dx.doi.org/10.1093/intimm/dxg054.
56. Wang CC, Fu CL, Yang YH, Lo YC, Wang LC, Chuang YH, Chang DM, Chiang BL. 2006. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma. Gene Ther. 13:1414–1421. http://dx.doi.org/10.1038/sj.gt.3302798.
57. Hitomi Y, Ebisawa M, Tomikawa M, Imai T, Komata T, Hirota T, Harada M, Sakashita M, Suzuki Y, Shimojo N, Kohno Y, Fujita K, Miyatake A, Doi S, Enomoto T, Taniguchi M, Higashi N, Nakamura Y, Tamari M. 2009. Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma. J. Allergy Clin. Immunol. 124:779–785.e6. http://dx.doi.org/10.1016/j.jaci.2009.07.044.
58. Besnard AG, Guillou N, Tschopp J, Erard F, Couillin I, Iwakura Y, Quesniaux V, Ryffel B, Togbe D. 2011. NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy 66:1047–1057. http://dx.doi.org/10.1111/j.1398-9995.2011.02586.x.
59. Allen IC, Jania CM, Wilson JE, Tekeppe EM, Hua X, Brickey WJ, Kwan M, Koller BH, Tilley SL, Ting JP. 2012. Analysis of NLRP3 in the development of allergic airway disease in mice. J. Immunol. 188: 2884–2893. http://dx.doi.org/10.4049/jimmunol.1102488.
60. Hara H, Tsuchiya K, Kawamura I, Fang R, Hernandez-Cuellar E, Shen Y, Mizuguchi J, Schweighoffer E, Tybulewicz V, Mitsuyama M. 2013. Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat. Immunol. 14:1247–1255. http://dx.doi.org/10.1038/ni.2749.
61. Qu Y, Misaghi S, Izrael-Tomasevic A, Newton K, Gilmour LL, Lamkanfi M, Louie S, Kayagaki N, Liu J, Kömüves L, Cupp JE, Arnott D, Monack D, Dixit VM. 2012. Phosphorylation of NLRC4 is critical for inflammasome activation. Nature 490:539–542. http://dx.doi.org/10.1038/nature11429.
62. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, Sher A, Kehrl JH. 2012. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat. Immunol. 13:255–263. http://dx.doi.org/10.1038/ni.2215.
63. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y, Bose S. 2009. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10:1073–1080. http://dx.doi.org/10.1038/ni.1782.
64. Tsai SY, Segovia JA, Chang TH, Morris IR, Berton MT, Tessier PA, Tardif MR, Cesaro A, Bose S. 2014. DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS Pathog. 10: e1003848. http://dx.doi.org/10.1371/journal.ppat.1003848.
65. Kannan TR, Musatovova O, Balasubramanian S, Cagle M, Jordan JL, Krunkosky TM, Davis A, Hardy RD, Baseman JB. 2010. Mycoplasma pneumoniae community acquired respiratory distress syndrome toxin expression reveals growth phase and infection-dependent regulation. Mol. Microbiol. 76:1127–1141. http://dx.doi.org/10.1111/j.1365-2958.2010.07092.x.